Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 8:22 PM View:  | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Grant | 18,757 | -- | -- | 36% 52.34K to 71.1K | |
| 05-Mar-24 8:22 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-24 | Sale | 3,756 | $53.76 | $201,923.00 | (5%) 71.1K to 67.34K | |
| 09-Feb-24 6:37 PM View: | Evolus, Inc. (EOLS) | 07-Feb-24 | Grant | 6,464 | -- | -- | 21% 31.24K to 37.71K | |
| 02-Feb-24 4:57 PM View: | Evolus, Inc. (EOLS) | 30-Jan-24 | Private Sale | 11,931 | $13.14 | $156,733.00 | (28%) 43.17K to 31.24K | |
| 05-May-23 2:16 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 04-May-23 | Sale (Planned) | 4,378 | $45.00 | $197,010.00 | (8%) 56.36K to 51.98K | |
| 03-Mar-23 10:00 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-23 | Grant | 24,663 | -- | -- | 71% 34.64K to 59.3K | |
| 03-Mar-23 10:00 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-23 | Sale | 3,161 | $45.25 | $143,035.00 | (5%) 59.3K to 56.14K | |
| 31-Jan-23 8:41 PM View: | Evolus, Inc. (EOLS) | 27-Jan-23 | Grant | 8,293 | -- | -- | 24% 34.88K to 43.17K | |
| 08-Mar-22 12:25 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 07-Mar-22 | Market Sale | 5,140 | $62.95 | $323,563.00 | (13%) 39.58K to 34.44K | (16%) |
| 03-Mar-22 6:08 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-22 | Grant | 14,000 | -- | -- | 49% 28.46K to 42.46K | |
| 03-Mar-22 6:08 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-22 | Sale | 2,886 | $66.62 | $192,265.00 | (7%) 42.46K to 39.58K | |
| 26-Jan-22 9:01 PM View: | Evolus, Inc. (EOLS) | 24-Jan-22 | Grant | 15,568 | -- | -- | 81% 19.31K to 34.88K | |
| 18-Oct-21 6:46 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 14-Oct-21 | Market Sale | 310 | $81.14 | $25,153.40 | (1%) 28.67K to 28.36K | 1% |
| 09-Sep-21 6:22 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 08-Sep-21 | Option Exercise | 7,336 | $54.50 | $399,812.00 | 26% 28.67K to 36.0K | |
| 09-Sep-21 6:22 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 08-Sep-21 | Market Option Sale | 7,336 | $100.65 | $738,368.00 | (20%) 36.0K to 28.67K | |
| 11-Jun-21 9:08 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 10-Jun-21 | Market Sale (Planned) | 1,329 | $100.00 | $132,900.00 | (4%) 30.0K to 28.67K | (10%) |
| 10-May-21 6:13 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-May-21 | Market Sale | 313 | $113.67 | $35,578.70 | (1%) 30.31K to 30.0K | (< 1%) |
| 03-Mar-21 8:47 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-21 | Grant | 10,136 | -- | -- | 42% 24.06K to 34.2K | |
| 03-Mar-21 8:47 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-21 | Market Sale | 3,970 | $138.17 | $548,535.00 | (12%) 34.2K to 30.23K | |
| 09-Feb-21 5:12 PM View: | Evolus, Inc. (EOLS) | 05-Feb-21 | Grant | 19,313 | -- | -- | 100% 0 to 19.31K | |
| 02-Nov-20 5:05 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 30-Oct-20 | Option Exercise | 9,903 | $54.50 | $539,714.00 | 41% 24.06K to 33.96K | 7% |
| 02-Nov-20 5:05 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 30-Oct-20 | Market Option Sale | 9,903 | $100.12 | $991,488.00 | (29%) 33.96K to 24.06K | (73%) |
| 30-Oct-20 5:28 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 28-Oct-20 | Option Exercise | 97 | $54.50 | $5,286.50 | < 1% 23.97K to 24.07K | 7% |
| 30-Oct-20 5:28 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 28-Oct-20 | Market Option Sale | 97 | $100.00 | $9,700.00 | (< 1%) 24.07K to 23.97K | (73%) |
| 16-Oct-20 7:21 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 14-Oct-20 | Market Sale | 325 | $88.00 | $28,600.00 | (1%) 24.29K to 23.97K | (96%) |
| 13-Oct-20 5:53 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 08-Oct-20 | Option Exercise | 10,000 | $54.50 | $545,000.00 | 41% 24.29K to 34.29K | 7% |
| 13-Oct-20 5:53 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 08-Oct-20 | Market Option Sale | 10,000 | $95.00 | $950,000.00 | (29%) 34.29K to 24.29K | (82%) |
| 07-Oct-20 2:57 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-Oct-20 | Option Exercise | 10,000 | $48.43 | $484,300.00 | 41% 24.29K to 34.29K | |
| 07-Oct-20 2:57 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-Oct-20 | Market Option Sale | 10,000 | $90.00 | $900,000.00 | (29%) 34.29K to 24.29K | (92%) |
| 24-Sep-20 4:47 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 23-Sep-20 | Option Exercise | 10,000 | $48.43 | $484,300.00 | 41% 24.29K to 34.29K | |
| 24-Sep-20 4:47 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 23-Sep-20 | Market Option Sale | 10,000 | $85.00 | $850,000.00 | (29%) 34.29K to 24.29K | (103%) |
| 19-Aug-20 2:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 17-Aug-20 | Option Exercise | 10,000 | $54.50 | $545,000.00 | 38% 26.66K to 36.66K | 7% |
| 19-Aug-20 2:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 17-Aug-20 | Market Option Sale | 10,000 | $88.43 | $884,304.00 | (27%) 36.66K to 26.66K | (95%) |
| 19-Aug-20 2:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 17-Aug-20 | Market Sale | 2,370 | $88.43 | $209,580.00 | (9%) 26.66K to 24.29K | (95%) |
| 22-Jun-20 1:46 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Jun-20 | Payment of Exercise | 649 | $78.22 | $50,764.80 | (2%) 27.31K to 26.66K | (121%) |
| 19-May-20 7:12 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 18-May-20 | Market Sale | 2,722 | $74.71 | $203,374.00 | (9%) 30.03K to 27.31K | (131%) |
| 08-May-20 8:02 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-May-20 | Payment of Exercise | 248 | $66.26 | $16,432.50 | (< 1%) 30.15K to 29.9K | (161%) |
| 21-Apr-20 3:36 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Apr-20 | Payment of Exercise | 248 | $58.57 | $14,525.40 | (< 1%) 30.4K to 30.15K | (195%) |
| 03-Mar-20 8:00 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-20 | Grant | 13,434 | -- | -- | 70% 19.08K to 32.52K | |
| 03-Mar-20 8:00 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-20 | Payment of Exercise | 2,118 | $56.08 | $118,777.00 | (7%) 32.52K to 30.4K | (208%) |
| 16-Oct-19 7:28 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 14-Oct-19 | Grant | 1,434 | -- | -- | 8% 17.65K to 19.08K | |
| 24-Jun-19 9:16 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 24-Jun-19 | Market Sale (Planned) | 1,226 | $61.50 | $75,399.00 | (6%) 18.88K to 17.65K | (181%) |
| 24-Jun-19 9:16 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 21-Jun-19 | Market Sale (Planned) | 1,489 | $63.01 | $93,821.90 | (7%) 20.36K to 18.88K | (174%) |
| 24-Jun-19 9:16 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 20-Jun-19 | Payment of Exercise | 649 | $63.48 | $41,198.50 | (3%) 21.01K to 20.36K | (172%) |
| 07-May-19 7:01 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 06-May-19 | Grant | 1,434 | -- | -- | 7% 19.58K to 21.01K | |
| 30-Apr-19 6:32 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 29-Apr-19 | Market Sale (Planned) | 468 | $68.30 | $31,964.40 | (2%) 20.05K to 19.58K | (153%) |
| 23-Apr-19 6:26 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Apr-19 | Payment of Exercise | 248 | $64.43 | $15,978.60 | (1%) 20.3K to 20.05K | (168%) |
| 04-Mar-19 5:04 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-19 | Grant | 7,000 | -- | -- | 49% 14.18K to 21.18K | |
| 04-Mar-19 5:04 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 01-Mar-19 | Payment of Exercise | 860 | $67.55 | $58,093.00 | (4%) 21.18K to 20.32K | (156%) |
| 21-Aug-18 6:59 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 21-Aug-18 | Market Sale | 5,000 | $78.53 | $392,650.00 | (35%) 14.18K to 9.18K | (120%) |